Hebei Weimiao Biology Co., LTD 1
Post
  • aħbarijiet

Blog

  • Exploring Pharmaceutical Intermediates

    Exploring Pharmaceutical Intermediates

    Pharma intermediates play a pivotal role in complex drug development processes and are key components in the synthesis of active pharmaceutical intermediates.
    Aqra iktar
  • Liraglutide Weight Loss Before and After: Transforming Lives Beyond Diabetes

    Liraglutide Weight Loss Before and After: Transforming Lives Beyond Diabetes

    Liraglutide drug, a GLP-1 receptor agonist, has become a game-changer not only in the treatment of diabetes, but also in the field of weight loss.
    Aqra iktar
  • What is the Difference Between Liraglutide and Semaglutide?

    What is the Difference Between Liraglutide and Semaglutide?

    Liraglutide and semaglutide are two different pharmaceutical preparations belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which are commonly liraglutide injection for weight loss and also used in the treatment of diabetes mellitus
    Aqra iktar
  • Pharmaceutical Intermediates Market

    Pharmaceutical Intermediates Market

    The pharmaceutical intermediate market is at the forefront of a complex network of drug development and manufacturing and is key to the production of active pharmaceutical intermediates.
    Aqra iktar
  • What exactly are “neuro” or “ocular” cases?

    X'inhuma eżattament każijiet "newro" jew "okulari"?

    Qattus "Neuro" ifisser li l-FIP qasmet il-barriera tad-demm-moħħ u s-sintomi jinkludu kwistjonijiet tas-sistema nervuża ċentrali. Atassja (dgħjufija fis-saqajn ta 'wara speċjalment), inkapaċità li jaqbeż kompletament mingħajr eżitazzjoni, nuqqas ta' koordinazzjoni u aċċessjonijiet jistgħu jseħħu. L-involviment okulari, li huwa komuni mal-forma newroloġika peress li l-għajnejn u l-moħħ huma konnessi mill-qrib, jidher bħal dan:
    Aqra iktar
  • GS-441524 is the biologically active component of Remdesivir

    GS-441524 huwa l-komponent bijoloġikament attiv ta 'Remdesivir

    GS-441524 huwa l-komponent bijoloġikament attiv ta 'Remdesivir u ġie użat ħafna madwar id-dinja biex tfejjaq b'mod sikur u effettiv il-qtates tal-peritonite infettiva tal-qtates (FlP) għal aktar minn 18-il xahar. FIP hija marda komuni u fatali ħafna tal-qtates.
    Aqra iktar
  • A newly developed powder 28578-16-7 PMK ethyl glycidate

    Trab żviluppat ġdid 28578-16-7 PMK ethyl glycidate

    Bid-domanda dejjem tikber tal-klijenti, bdejna wkoll jonfqu ħafna ħin u enerġija biex ninvestu fir-riċerka u l-iżvilupp ta 'dan il-prodott ġdid ta' trab pmk, il-purità titjieb ħafna. Il-ħażna hija aktar konvenjenti, u x-xerrejja huma mistiedna jagħmlu ordnijiet kbar.
    Aqra iktar

Jekk inti interessat fil-prodotti tagħna, tista 'tagħżel li tħalli l-informazzjoni tiegħek hawn, u aħna ser inkunu f'kuntatt miegħek dalwaqt.


mtMaltese